Helen Torley, President and CEO: Halozyme Therapeutics HALO Sell · Filed 25/08/13

Trade details

Type: Insider sale
Amount: $1,179,358.17
Shares · price: 18,717 sh · $63.01 a share
Held after: 735,002 sh
Stock: Halozyme Therapeutics HALO
Person: Helen TorleyPresident and CEO
Trade date: 25/08/11
Filed: 25/08/13
Days to filing: 2 days

Sold 2.5% of holdings

Share of holding sold: 2.5%

Halozyme Therapeutics trades, last 26 weeks

What else happened in Halozyme Therapeutics around then

Filed or reported within 30 days of the trade day · 25/07/12~25/09/10

Helen Torley's recent trades

Helen TorleyPresident and CEO
Planned sale10b5-1 planHalozyme Therapeutics
Planned sale10b5-1 plan
Halozyme Therapeutics
HALO
$23.7M
240,000 sh
$23.7M
Filed 08/17
Traded 08/17
Helen TorleyPresident and CEO
Sell10b5-1 planHalozyme Therapeutics
Sell10b5-1 plan
Halozyme Therapeutics
HALO
$1.1M
16,600 sh
$1.1M
Filed 06/03
Traded 06/02
Helen TorleyPresident and CEO
Sell10b5-1 planHalozyme Therapeutics
Sell10b5-1 plan
Halozyme Therapeutics
HALO
$875.6K
12,989 sh
$875.6K
Filed 06/03
Traded 06/01
Helen TorleyPresident and CEO
Sell10b5-1 planHalozyme Therapeutics
Sell10b5-1 plan
Halozyme Therapeutics
HALO
$425.1K
6,100 sh
$425.1K
Filed 06/03
Traded 06/03
Helen TorleyPresident and CEO
Sell10b5-1 planHalozyme Therapeutics
Sell10b5-1 plan
Halozyme Therapeutics
HALO
$369.2K
5,401 sh
$369.2K
Filed 06/03
Traded 06/01

Helen Torley, CEO — sold $1.2M of Halozyme Therapeutics HALO · 2.5% of holdings · 10b5-1 plan | Whalegun